Rosen Law Firm Announces Investigation Of China Nuokang Bio-Pharmaceutical In Connection With Going Private Proposal From Kingbird Investment Inc. – NKBP
The Rosen Law Firm is investigating the Board of Directors of China Nuokang Bio-Pharmaceutical Inc. (NASDAQ: NKBP) for possible breaches of fiduciary duty and other violations of corporate law in connection with a going private proposal from Kingbird Investment Inc., beneficially owned by Ms. Yuhuan Zhu – the wife of Nuokang's Chairman and CEO, Mr. Baizhong Xue.
If you would like to join the action please email or call Phillip Kim or Kevin Chan, toll-free, at 866-767-3653; or email at firstname.lastname@example.org or email@example.com. There is no cost or obligation to you.
Under the terms of the proposal, offered by Kingbird Investment, shareholders will receive $5.80 for each American Depository Share (“ADS”) or $0.725 for each common share of Nuokang they own. The investigation relates to whether the proposal for $5.80/ADS is fair to public shareholders and whether Nuokang’s Board fiduciary duties in connection with the offer.
If you own shares of Nuokang and wish to obtain additional information, you may contact Phillip Kim or Kevin Chan of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at firstname.lastname@example.org or email@example.com.The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Attorney Advertising. Prior results do not guarantee a similar outcome.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV